Eph receptor B3 (EPHB3) Rabbit Polyclonal Antibody
CAT#: TA366848
EPHB3 rabbit polyclonal antibody
Size: 25 ul
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 1999.00
CNY 3280.00
                                                
                                                
                                                
                                                    CNY 300.00 
                                                    
                                                    CNY 1430.00
                                                
                                            
Specifications
| Product Data | |
| Applications | IHC, WB | 
| Recommend Dilution | WB: 200-1000 WB positive control: Hela and 231 cell IHC: 50-200 Positive control: Human thyroid cancer Predicted cell location: Cytoplasm  | 
        
| Reactivity | Human, Mouse | 
| Host | Rabbit | 
| Clonality | Polyclonal | 
| Immunogen | Synthetic peptide of human EPHB3 | 
| Isotype | IgG | 
| Formulation | pH7.4 PBS, 0.05% NaN3, 40% Glycerol | 
| Concentration | lot specific | 
| Purification | Antigen affinity purification | 
| Conjugation | Unconjugated | 
| Storage Condition | Store at -20°C. | 
| Predicted Protein Size | 110 kDa | 
| Gene Name | EPH receptor B3 | 
| Database Link | |
| Background | Ephrin receptors and their ligands, the ephrins, mediate numerous developmental processes, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are divided into two groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. | 
| Synonyms | ETK2; HEK2; TYRO6 | 
| Reference Data | |
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
